Fatal dural sinus thrombosis associated with heterozygous factor V Leiden and a short activated partial thromboplastin time

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 10, 2003, Pages 1359-1361

  Stephan, Christina L ^a   SantaCruz, Karen ^b   May, Corrie ^a   Wilkinson, Steve B ^a   Cunningham, Mark T ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; DURA MATER SINUS THROMBOSIS; FATALITY; FEMALE; GENE MUTATION; HERNIA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LUNG EMBOLISM; MICROSCOPY; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; RISK FACTOR; SYMPTOMATOLOGY; THROMBOPHILIA;

FACTOR V; FATAL OUTCOME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUTATION; PARTIAL THROMBOPLASTIN TIME; SINUS THROMBOSIS, INTRACRANIAL;

EID: 0141891852     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis. Postgrad Med J. 2000;76:12-15.
2. Bertina RM. Molecular risk factors for thrombosis. Thromb Haemost. 1999;82:601-609.
3. Van Gijn J. Cerebral venous thrombosis: pathogenesis, presentation and prognosis. J R Soc Med. 2000;93:230-233.
4. Ludemann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke. 1998;29:2507-2510.
5. Martinelli I, Landi G, Merati G, et al. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394.
6. McKenna R, Bachmann F, Miro-Quesada M. Thrombo-embolism in patients with abnormally short activated partial thromboplastin time. Thromb Haemost. 1977;38:893-899.
7. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457-462.
8. Edson JR, Krivit W, White JG. Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. J Lab Clin Med. 1967;70:463-470.
9. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-1231.
10. Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793-1797.